Penserra Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Penserra Capital Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-960	Closed	-$69K	–	1442
2021 Q3	$69K	Buy	960 +235	+32%	+$17K	﹤0.01%	951
2021 Q2	$60K	Buy	725 +305	+73%	+$20.1K	﹤0.01%	950
2021 Q1	$20K	Buy	420 +60	+17%	+$3.25K	﹤0.01%	966
2020 Q4	$16K	Buy	+360	New	+$14.2K	﹤0.01%	876

Other funds holding NBP

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ZAM

Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Penserra Capital Management's NBP Position: Q4 2021 in Review

Penserra Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2021, closing a stake of 960 shares — an estimated $69K sold.

Penserra Capital Management first reported a position in NBP in Q4 2020 and held it in 4 quarters. The position peaked at $69K in Q3 2021. 132 funds tracked by Wall St. Rank hold NBP as of Q4 2021.

Penserra Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Penserra Capital Management sold 960 NovaBridge Biosciences American Depositary Shares shares in Q4 2021, an estimated $69K.
Penserra Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 4 quarters.
Penserra Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $69K in Q3 2021.
132 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.